FREE CASE EVALUATION: +1-888-885-2771                                          Email us:


Johnson & Johnson faces new talc cancer trial amid settlement push.

J&J Faces New Trial Over Talc Cancer Claims, Amid Settlement Push - Johnson & Johnson (JNJ.N) faced its first trial in nearly two years on Wednesday over claims that asbestos in its baby powder and other talc products caused cancer, as the company works to resolve thousands of similar cases in bankruptcy court.

Emory Hernandez, 24, claims he contracted mesothelioma, a lethal illness, in the tissue surrounding his heart as a result of his childhood exposure to J&J’s talc products. The corporation has denied that its talc includes asbestos, which has been linked to mesothelioma and is carcinogenic.

Hernandez’s attorney, Joseph Satterley, urged jurors in Alameda County, California, to reject the company’s defenses and hold it accountable for his client’s condition.

“I can assure you that the evidence will be very strong,” Satterley said. “Mesothelioma is the signature disease of asbestos.”

In her opening remarks, Allison Brown, a J&J lawyer, stated that the corporation went to great efforts to guarantee that there were no impurities in its talc. Hernandez’s type of mesothelioma, she noted, was extremely rare and was most likely caused by a family history of heart illness and cancer.

“We have never wavered in our belief that talc is safe and does not cause cancer,” she explained.

J&J subsidiary LTL Management filed for bankruptcy in Trenton, New Jersey in April, seeking to pay $8.9 billion to resolve more than 38,000 complaints and prevent new ones from being filed. It is the company’s second attempt to settle talc claims in bankruptcy, following the rejection of an earlier bid by a federal appeals court.

Although most litigation has been delayed during the bankruptcy proceedings, U.S. Chief Bankruptcy Judge Michael Kaplan, who is supervising LTL’s Chapter 11, allowed Hernandez’s trial to proceed because he is only anticipated to live for a limited time.

Even if Hernandez prevails, he will be unable to collect on the judgment while the bankruptcy proceedings are ongoing.

Nonetheless, the trial decision may impact whether other plaintiffs decide to join the proposed settlement.

Asbestos plaintiffs are attempting to have the current bankruptcy file dismissed, claiming it was brought in bad faith to shield the corporation from litigation.

J&J and LTL have maintained that bankruptcy provides more fair, efficient, and equitable settlement payouts than a “lottery” afforded by trial courts, in which some litigants receive substantial damages while others receive nothing.

In bankruptcy court documents, the corporation stated that the expenses of its talc-related judgments, settlements, and legal fees have risen to almost $4.5 billion. will keep readers posted on any new developments in the Johnson and Johnson talc settlement.

Our team of medical experts and legal professionals can assist you if you are unsure whether you are eligible for a talc powder lawsuit settlement. Fill out our contact form today for a free case review.

One reply on “Johnson & Johnson faces new talc cancer trial amid settlement push.”

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Your Free

Case Evaluation!

The fee is free, you only pay when you win!

Recent News


Sharing is caring.. ?


Get Your compensation now, before it gets too late

The fee is free, you only pay when you win. Get Free Consultation from our expert lawyers.

The Justice Now Legal News

The biggest loser — workers’ compensation?

When you see a person you’ve not seen for several months, You’re probably to ask: “Gee, you look great. Have you lost weight?” The most likely answer is Ozempic Wegovy and Mounjaro. Ozempic, as well as Mounjaro, were designed for treating Type 2 diabetes; Wegovy explicitly intended to be a weight-loss drug, making use of the same semaglutide formulation used in Ozempic.

The Justice Now Legal News

Doctor asks court to toss J&J lawsuit against her over cancer research

A medical scientist has asked the court to dismiss the lawsuit Johnson & Johnson brought against her for her 2019 research on the link between cosmetic talc and cancer. She argued that her work is reliable and is protected by the freedom of speech rights.

The Justice Now Legal News

Appeals court OKs ‘common benefit’ fees in Bard IVC filter litigation. Next stop the Supreme Court?

Appeals court OKs ‘common benefit’ fees in Bard IVC filter litigation. Next stop the Supreme Court? – Lawyers representing plaintiffs who have signed agreements to pay a portion of their fee to chiefs of significant multidistrict litigation have to respect those agreements even if they decide to settle disputes outside the process, as per a federal appeals court ruling that week.

The Justice Now Legal News

Navy, Justice Dept. offer payouts in bid to speed up Camp Lejeune claims

The United States Department of Justice and U.S. Navy announced a program of tier-based payouts to those whom the water contamination on Marine Corps Base Camp Lejeune has harmed.

Ozempic Lawsuit

Ozempic Lawsuit: What you need to know

Ozempic Lawsuit: What you need to know – Ozempic (semaglutide) is an injection of 0.5- 2 mg, an injectable prescribed medicine used by type 2 – diabetic patients to lower the risk of heart attack, stroke, or death. Also, some of them are used for weight loss.

Bard PowerPort Catheter Lawsuit

All You Need to Know About Bard PowerPort Catheter Lawsuit: Latest Updates 2023 and Eligibility Criteria

Bard Powerport Catheter Lawsuit Updates 2023

You might also like...

One reply on “Johnson & Johnson faces new talc cancer trial amid settlement push.”

Leave a Reply

Your email address will not be published. Required fields are marked *

Free Consultation?

Fill out your details and we will get back to you as soon as possible.